SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-007123
Filing Date
2018-06-28
Accepted
2018-06-28 17:06:03
Documents
5
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT kyto_10k.htm 10-K 587395
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kyto_ex311.htm EX-31.1 20850
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF kyto_ex312.htm EX-31.2 20282
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE kyto_ex321.htm EX-32.1 9211
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE kyto_ex322.htm EX-32.2 8948
  Complete submission text file 0001654954-18-007123.txt   647812
Mailing Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401
Business Address 500 AUSTRALIAN AVENUE S. SUITE 600 WEST PALM BEACH FL 33401 416-955-0159
KYTO BIOPHARMA INC (Filer) CIK: 0001164888 (see all company filings)

IRS No.: 651086538 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50390 | Film No.: 18926181
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences